Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check6 days agoChange DetectedThe record history now shows a new site revision (v3.6.6) replacing the previous revision (v3.6.5), indicating a software update to the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe site's revision label in the footer was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a deployed update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check42 days agoChange DetectedThe footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release update.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new site version was applied to render this page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, indicating a site software update rather than changes to the study history content.SummaryDifference0.0%

- Check78 days agoChange DetectedA new study version (73) was posted on 2026-06-15, updating the Study Status in the record history. A follow-up entry on 2026-06-16 reinforces the current status, and a deletion on 2026-03-18 removes prior data from the history.SummaryDifference0.2%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.